Eli Lilly Is Resilient
471781
The company is ready to handle competition from generics.
611251
Eli Lilly and Co on Tuesday said U.S.  regulators approved once-daily use of two low-dose forms of its  Cialis anti-impotence drug, offering greater convenience for  men expecting frequent sexual activity.
66523
Drug-coated stent maker Boston Scientific rebounds from recall with strong growth.
433289
The large-cap drugmaker keeps giving investors reason to cheer.
638974
By Luke Timmerman, Seattle Times  Dec. 19--Eli Lilly raised its bid for Icos to $34 a share Monday in a last-minute change of strategy, but a major shareholder who opposed the original $32 price vowed to continue pushing for more.
118432
The US Food and Drug Administration (FDA) has approved the Eli Lilly drug Alimta, for the treatment of advanced non-small cell lung cancer in previously treated patients.
432135
The Food and Drug Administration yesterday approved a cancer drug made by pharmaceutical giant Eli Lilly and Co. to treat advanced non-small cell lung cancer in patients who have undergone chemotherapy.
453137
An experimental drug from Eli Lilly reduced heart attacks in patients with heart disease by 24 percent compared with the current standard treatment.
245874
Eli Lilly and Co.  said on Thursday it is on track to meet its 2006 growth forecast of 8 percent to 12 percent, but projected slower profit growth in 2007 though its revenues will grow at a faster pace next year.
2830
Analysts expect continued growth despite a tough environment.
615212
Eli Lilly and Co. LLY.N on Thursday  said it expects earnings in 2005 to rise to between $3.05 and  $3.15 per share before special items as growing sales of newer  medicines more than offset disappointing sales of its  top-selling schizophrenia drug.
287117
Drug company Eli Lilly  has encouraged primary care physicians to use Zyprexa, a powerful drug for schizophrenia and bipolar disorder, in patients who did not have either condition, the New York Times reported on its Web site on Monday, citing internal Lilly marketing materials.
733339
Eli Lilly and Co.  on Tuesday posted better-than-expected quarterly earnings and raised its 2007 forecast, helped by surging sales of its prescription drugs, including depression treatment Cymbalta.
79075
Eli Lilly pushed Zyprexa, a drug for schizophrenia and bipolar disorder, as a treatment for older patients with dementia, according to marketing materials.
164709
The company's stock has had a rough few months, but the business still looks strong.
322734
The US pharmaceutical industry endured a disastrous 2004, and the aftermath will linger into the new year. Regulators at the Food and Drug Administration (FDA) were already expected
245346
Drug giant Eli Lilly has engaged in a decade-long effort to play down the health risks of its top-selling medication, the schizophrenia drug Zyprexa, The New York Times reported in Sunday editions.